1. China Pharma Firm Accused of Ghost Patients, Fake Trials
Whispers from within the Chinese pharmaceutical industry point to widespread fraudulent practices involving clinical trials. A prominent domestic firm, reportedly specializing in oncology drugs, is under intense scrutiny for allegedly fabricating patient data and creating 'ghost patients' to inflate trial success rates...